Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation. / Taaning, E; Jacobsen, N; Morling, N.

In: British Journal of Haematology, Vol. 86, No. 3, 1994, p. 651-3.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Taaning, E, Jacobsen, N & Morling, N 1994, 'Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation', British Journal of Haematology, vol. 86, no. 3, pp. 651-3.

APA

Taaning, E., Jacobsen, N., & Morling, N. (1994). Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation. British Journal of Haematology, 86(3), 651-3.

Vancouver

Taaning E, Jacobsen N, Morling N. Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation. British Journal of Haematology. 1994;86(3):651-3.

Author

Taaning, E ; Jacobsen, N ; Morling, N. / Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation. In: British Journal of Haematology. 1994 ; Vol. 86, No. 3. pp. 651-3.

Bibtex

@article{06d76b70e4b811deba73000ea68e967b,
title = "Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation",
abstract = "We report on a male who received a bone-marrow allograft from his HLA identical sister for acute myelogenous leukaemia. After transplantation, the patient suffered from refractoriness to the transfusions of HLA-matched platelets and a strong platelet-specific antibody, anti-HPA-2b, of IgG1 subclass was demonstrated in the patient's serum. In the serum of the bone-marrow donor a weak IgG1 anti-HPA-2b was demonstrated. IgG allotyping of the patient and donor showed identical results. We could not determine the origin of the anti-HPA-2b, although we hypothesize that the anti-HPA-2b was produced by immunocompetent donor lymphocytes infused with the suspension of bone-marrow cells.",
author = "E Taaning and N Jacobsen and N Morling",
note = "Keywords: Antigens, Human Platelet; Blood Platelets; Bone Marrow Transplantation; Humans; Immunoglobulin G; Leukemia, Myeloid, Acute; Male; Middle Aged; Platelet Count; Platelet Transfusion; Transplantation, Homologous",
year = "1994",
language = "English",
volume = "86",
pages = "651--3",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation

AU - Taaning, E

AU - Jacobsen, N

AU - Morling, N

N1 - Keywords: Antigens, Human Platelet; Blood Platelets; Bone Marrow Transplantation; Humans; Immunoglobulin G; Leukemia, Myeloid, Acute; Male; Middle Aged; Platelet Count; Platelet Transfusion; Transplantation, Homologous

PY - 1994

Y1 - 1994

N2 - We report on a male who received a bone-marrow allograft from his HLA identical sister for acute myelogenous leukaemia. After transplantation, the patient suffered from refractoriness to the transfusions of HLA-matched platelets and a strong platelet-specific antibody, anti-HPA-2b, of IgG1 subclass was demonstrated in the patient's serum. In the serum of the bone-marrow donor a weak IgG1 anti-HPA-2b was demonstrated. IgG allotyping of the patient and donor showed identical results. We could not determine the origin of the anti-HPA-2b, although we hypothesize that the anti-HPA-2b was produced by immunocompetent donor lymphocytes infused with the suspension of bone-marrow cells.

AB - We report on a male who received a bone-marrow allograft from his HLA identical sister for acute myelogenous leukaemia. After transplantation, the patient suffered from refractoriness to the transfusions of HLA-matched platelets and a strong platelet-specific antibody, anti-HPA-2b, of IgG1 subclass was demonstrated in the patient's serum. In the serum of the bone-marrow donor a weak IgG1 anti-HPA-2b was demonstrated. IgG allotyping of the patient and donor showed identical results. We could not determine the origin of the anti-HPA-2b, although we hypothesize that the anti-HPA-2b was produced by immunocompetent donor lymphocytes infused with the suspension of bone-marrow cells.

M3 - Journal article

C2 - 8043449

VL - 86

SP - 651

EP - 653

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -

ID: 16186154